Citation: Da. Zanis et Ge. Woody, ONE-YEAR MORTALITY-RATES FOLLOWING METHADONE TREATMENT DISCHARGE, Drug and alcohol dependence, 52(3), 1998, pp. 257-260
Authors:
CORNISH JW
METZGER D
WOODY GE
WILSON D
MCLELLAN AT
VANDERGRIFT B
OBRIEN CP
Citation: Jw. Cornish et al., NALTREXONE PHARMACOTHERAPY FOR OPIOID DEPENDENT FEDERAL PROBATIONERS, Journal of substance abuse treatment, 14(6), 1997, pp. 529-534
Authors:
FRANK AP
WANDELL MG
HEADINGS MD
CONANT MA
WOODY GE
MICHEL C
Citation: Ap. Frank et al., ANONYMOUS HIV TESTING USING HOME COLLECTION AND TELEMEDICINE COUNSELING - A MULTICENTER EVALUATION, Archives of internal medicine, 157(3), 1997, pp. 309-314
Citation: At. Mclellan et al., EVALUATING THE EFFECTIVENESS OF ADDICTION TREATMENTS - REASONABLE EXPECTATIONS, APPROPRIATE COMPARISONS, The Milbank quarterly, 74(1), 1996, pp. 51
Authors:
ALTERMAN AI
RUTHERFORD MJ
CACCIOLA JS
MCKAY JR
WOODY GE
Citation: Ai. Alterman et al., RESPONSE TO METHADONE-MAINTENANCE AND COUNSELING IN ANTISOCIAL PATIENTS WITH AND WITHOUT MAJOR DEPRESSION, The Journal of nervous and mental disease, 184(11), 1996, pp. 695-702
Authors:
MEYERS K
METZGER DS
MCLELLAN AT
NAVALINE H
SHEON AR
WOODY GE
Citation: K. Meyers et al., WILL PREVENTIVE HIV VACCINE EFFICACY TRIALS BE POSSIBLE WITH FEMALE INJECTION-DRUG USERS, Journal of acquired immune deficiency syndromes and human retrovirology, 10(5), 1995, pp. 577-585
Authors:
DAVIS RF
METZGER DS
MEYERS K
MCLELLAN AT
MULVANEY FD
NAVALINE HA
WOODY GE
Citation: Rf. Davis et al., LONG-TERM CHANGES IN PSYCHOLOGICAL SYMPTOMATOLOGY ASSOCIATED WITH HIVSEROSTATUS AMONG MALE INJECTING DRUG-USERS, AIDS, 9(1), 1995, pp. 73-79
Authors:
WOODY GE
MCLELLAN AT
LUBORSKY L
OBRIEN CP
Citation: Ge. Woody et al., PSYCHOTHERAPY IN COMMUNITY METHADONE PROGRAMS - A VALIDATION-STUDY, The American journal of psychiatry, 152(9), 1995, pp. 1302-1308
Citation: Ge. Woody et al., PREPARATIONS FOR AIDS VACCINE TRIALS - RECRUITMENT AND RETENTION OF IN-TREATMENT AND OUT-OF-TREATMENT INJECTION-DRUG USERS, AIDS research and human retroviruses, 10, 1994, pp. 190000197-190000199
Authors:
NAVALINE HA
SNIDER EC
PETRO CJ
TOBIN D
METZGER D
ALTERMAN AI
WOODY GE
Citation: Ha. Navaline et al., PREPARATIONS FOR AIDS VACCINE TRIALS - AN AUTOMATED VERSION OF THE RISK ASSESSMENT BATTERY (RAB) - ENHANCING THE ASSESSMENT OF RISK BEHAVIORS, AIDS research and human retroviruses, 10, 1994, pp. 190000281-190000283
Authors:
ARNDT IO
MCLELLAN AT
DOROZYNSKY L
WOODY GE
OBRIEN CP
Citation: Io. Arndt et al., DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE - ROLE OF ANTISOCIAL PERSONALITY-DISORDER, The Journal of nervous and mental disease, 182(3), 1994, pp. 151-156
Authors:
MCLELLAN AT
ALTERMAN AI
METZGER DS
GRISSOM GR
WOODY GE
LUBORSKY L
OBRIEN CP
Citation: At. Mclellan et al., SIMILARITY OF OUTCOME PREDICTORS ACROSS OPIATE, COCAINE, AND ALCOHOL TREATMENTS - ROLE OF TREATMENT SERVICES, Journal of consulting and clinical psychology, 62(6), 1994, pp. 1141-1158
Authors:
GALANTER M
PEYSER HS
WALKER RD
WOODY GE
FLAVIN DK
JAFFE JH
UNGERLEIDER JT
CZECHOWICZ DJ
SUCHINSKY RT
KOPLIN B
Citation: M. Galanter et al., POSITION STATEMENT ON THE NEED FOR IMPROVED TRAINING FOR TREATMENT OFPATIENTS WITH COMBINED SUBSTANCE USE AND OTHER PSYCHIATRIC-DISORDERS, The American journal of psychiatry, 151(5), 1994, pp. 795-796
Authors:
METZGER DS
WOODY GE
MCLELLAN AT
OBRIEN CP
DRULEY P
NAVALINE H
DEPHILIPPIS D
STOLLEY P
ABRUTYN E
Citation: Ds. Metzger et al., HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION AMONG INTRAVENOUS-DRUG-USERS IN-OF-TREATMENT AND OUT-OF-TREATMENT - AN 18-MONTH PROSPECTIVE FOLLOW-UP, Journal of acquired immune deficiency syndromes, 6(9), 1993, pp. 1049-1056